During her career, Gayle has directed and participated in some of the most innovative life science developments in the country. Her work has been focused on innovative translational research campuses and urban revitalization projects involving some of the nation’s most respected research universities, hospitals and bioscience companies. Her recent work as head of GB Farris Strategies has focused around the creation of university innovation cluster campuses and state of the art research facilities including a major planning effort with Harvard University on its Allston campus.
Gayle also spent 25 years as the CEO of Forest City Enterprises Science & Technology Group where she directed the conceptualization, planning and execution of some of the most innovative translational research and life science projects in the country. Her work during this period included the following:
+ University Park @ MIT – 2.3 million square foot, 27-acre bioscience and mixed-use development adjacent to the Massachusetts Institute of Technology in Cambridge, MA. The campus includes research, R&D and commercial facilities for Novartis, Takada Oncology, Mass General and Brigham & Women’s Hospital.
+ Science & Tech Park @ Johns Hopkins – Revitalization of an 88-acre Baltimore neighborhood through a public private partnership anchored by Johns Hopkins. The project includes a 277,000 sq ft biomedical research facility, a 165,000 sq ft life science incubator, and a 235,000 sq ft public health lab.
+ University of Pennsylvania Translational Research Labs – Strategic partnership with Penn to create a wet-bench biomedical research facility that includes 77,100 sq ft of lab space, a vivarium and ancillary support spaces.